RE:RE:RE:BG pillWith a cinical study backed by the MHI, it may not be a difficult sell. We won't know how doctors may react if a patient asks about a BG pill. They have a interest in recommending drugs.
Gilles has a vision for the company, as he has said, he wants to transition to being a biopharma company and the valuation would be many times the current market cap.Getting there of course is another story. PGX is a delivery system (s) [inhalable, sublingual, derma, etc.] which can be impregnated with different bio-actives. This makes it a very versatile chemical complex with endless applications to treat various ailments. It will up to Gilles and the team to unlock the potential of PGX. I believe Gilles has a lot of confidence in PGX, he has said that an "event" (ie. deal) would move up the share price significantly. Pehaps his confidence in this precludes him from worrying about shareholder communications for now.
I may be incorrect in my thoughts, as I'm just trying to connect the dots through the interpretation of public information.
Alex1726 wrote: Thank you i appreciate your answers , but we all know that patients listen to what doctors says and that include myself , if no doctors says to no one to take the pill well i do not need to elaborate. You will need a big promo campaing to make that pill a good seller.
initially companies wanted to license PGX tech, vs. chemical complexes -
Don't you think that if a multi-national would want the farm he could not have it? CZO is only a $53M market cap.